Intervacc AB (IVACC) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.094x

Based on the latest financial reports, Intervacc AB (IVACC) has a cash flow conversion efficiency ratio of -0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-29.33 Million ≈ $-3.16 Million USD) by net assets (Skr310.46 Million ≈ $33.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Intervacc AB net asset quality index to measure how much of total assets are equity-financed.

Intervacc AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Intervacc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IVACC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Intervacc AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intervacc AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
E& Corporation CO. LTD KQ:066980	0.016x
Yufo Electronics Co Ltd TWO:6194	0.045x
Grupo Concesionario del Oeste SA BA:OEST	0.020x
Mister Spex SE F:MRX	0.007x
Fractal Gaming Group AB ST:FRACTL	0.071x
Equus Energy Ltd AU:EQU	-0.161x
Renishaw PLC LSE:RSW	0.040x
Asian Pac Holdings Bhd KLSE:4057	0.018x

Annual Cash Flow Conversion Efficiency for Intervacc AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Intervacc AB from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Intervacc AB (IVACC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr162.33 Million ≈ $17.47 Million	Skr-53.20 Million ≈ $-5.72 Million	-0.328x	-70.11%
2023-12-31	Skr237.93 Million ≈ $25.61 Million	Skr-45.83 Million ≈ $-4.93 Million	-0.193x	+30.95%
2022-12-31	Skr250.16 Million ≈ $26.92 Million	Skr-69.79 Million ≈ $-7.51 Million	-0.279x	-237.73%
2021-12-31	Skr308.25 Million ≈ $33.17 Million	Skr-25.46 Million ≈ $-2.74 Million	-0.083x	-38.88%
2020-12-31	Skr337.61 Million ≈ $36.33 Million	Skr-20.08 Million ≈ $-2.16 Million	-0.059x	-372.02%
2019-12-31	Skr219.82 Million ≈ $23.66 Million	Skr-2.77 Million ≈ $-298.10K	-0.013x	+40.50%
2018-12-31	Skr190.43 Million ≈ $20.49 Million	Skr-4.03 Million ≈ $-434.02K	-0.021x	+81.77%
2017-12-31	Skr164.90 Million ≈ $17.75 Million	Skr-19.16 Million ≈ $-2.06 Million	-0.116x	-260.12%
2016-12-31	Skr130.18 Million ≈ $14.01 Million	Skr-4.20 Million ≈ $-451.99K	-0.032x	+78.61%
2015-12-31	Skr126.52 Million ≈ $13.62 Million	Skr-19.09 Million ≈ $-2.05 Million	-0.151x	--

About Intervacc AB

ST:IVACC Sweden Biotechnology

Market Cap

$44.89 Million

Skr417.16 Million SEK

Market Cap Rank

#22256 Global

#420 in Sweden

Share Price

Skr1.22

Change (1 day)

-3.62%

52-Week Range

Skr0.61 - Skr1.39

All Time High

Skr89.40